Uxin (UXIN) Cost of Revenue (2017 - 2025)

Uxin has reported Cost of Revenue for 9 years, with the latest figure at $17.5 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 106.62% year-over-year to $17.5 million; the trailing twelve-month figure through Dec 2025 stood at $36.4 million (down 6.22% YoY), and the FY2025 full-year result was $50.0 million, up 59.95% from the prior year.
• Cost of Revenue for Q4 2025 stood at $17.5 million, up from $12741.9 in the prior quarter.
• The five-year high for Cost of Revenue was $47401.4 billion in Q2 2023, with the low at $9.83 in Q2 2022.
• Historically, Cost of Revenue has averaged $2370.9 billion across 5 years, with a median of $7.5 million in 2024.
• Annual changes were most pronounced in 2023 — Cost of Revenue surged 482386413092111.06% — and 2024, when it plunged 100.0%.
• Uxin's Cost of Revenue stood at $10.6 billion in 2021, then plunged by 100.0% to $7967.0 in 2022, then gained by 0.21% to $7984.0 in 2023, then soared by 105912.02% to $8.5 million in 2024, then surged by 106.62% to $17.5 million in 2025.
• The last three Cost of Revenue figures came in at $17.5 million (Q4 2025), $12741.9 (Q3 2025), and $10.4 million (Q2 2025), per Business Quant data.